AKT1 and hypercalcemia disease: The inhibitory effect of emodin was reversed by the addition of AKT activator, suggesting that emodin alleviated hypercalcemia-associated valve calcification by inhibiting AKT/FOXO1 signaling (Luo et al., 2022).